Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × edoxaban × Clear all

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

Data Collection 24 Blood Specimen Collection 24 Nivolumab 23 Sorafenib 22 Bevacizumab 20 palbociclib 19 Observation 18 radium Ra 223 dichloride 17 Sunitinib 17 enzalutamide 16 Rituximab 15 Trastuzumab 13 ribociclib 12 regorafenib 12 exemestane 12 atezolizumab 11 Leuprolide 11 Ipilimumab 11 Docetaxel 11 apalutamide 10 Standard of Care 10 Drug Therapy 10 Capecitabine 10 Bortezomib 10 Afatinib 10 Therapeutics 9 Cetuximab 9 Anastrozole 9 Abiraterone Acetate 9 Rivaroxaban 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡